Biogen, Inc. (BIIB)
Biogen Market Cap: 26.70B for Dec. 4, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 183.17B |
| Eli Lilly & Co. | 907.99B |
| Merck & Co., Inc. | 250.41B |
| Pfizer Inc. | 146.12B |
| Stoke Therapeutics, Inc. | 1.773B |
Market Cap Related Metrics
| PE Ratio | 16.60 |
| PS Ratio | 2.754 |
| Price to Book Value | 1.466 |
| Price to Free Cash Flow | 11.80 |
| Price | 181.98 |
| Earnings Yield | 6.03% |
| Operating PE Ratio | 10.94 |
| Normalized PE Ratio | 14.71 |